Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies

Abstract Cerebrospinal fluid (CSF) is a clear, transparent fluid derived from blood plasma that protects the brain and spinal cord against mechanical shock, provides buoyancy, clears metabolic waste and transports extracellular components to remote sites in the brain. Given its contact with the brain and the spinal cord, CSF is the most informative biofluid for studies of the central nervous system (CNS). In addition to other components, CSF contains extracellular vesicles (EVs) that carry bioactive cargoes (e.g., lipids, nucleic acids, proteins), and that can have biological functions within and beyond the CNS. Thus, CSF EVs likely serve as both mediators of and contributors to communication in the CNS. Accordingly, their potential as biomarkers for CNS diseases has stimulated much excitement for and attention to CSF EV research. However, studies on CSF EVs present unique challenges relative to EV studies in other biofluids, including the invasive nature of CSF collection, limited CSF volumes and the low numbers of EVs in CSF as compared to plasma. Here, the objectives of the International Society for Extracellular Vesicles CSF Task Force are to promote the reproducibility of CSF EV studies by providing current reporting and best practices, and recommendations and reporting guidelines, for CSF EV studies. To accomplish this, we created and distributed a world‐wide survey to ISEV members to assess methods considered ‘best practices’ for CSF EVs, then performed a detailed literature review for CSF EV publications that was used to curate methods and resources. Based on responses to the survey and curated information from publications, the CSF Task Force herein provides recommendations and reporting guidelines to promote the reproducibility of CSF EV studies in seven domains: (i) CSF Collection, Processing, and Storage; (ii) CSF EV Separation/Concentration; (iii) CSF EV Size and Number Measurements; (iv) CSF EV Protein Studies; (v) CSF EV RNA Studies; (vi) CSF EV Omics Studies and (vii) CSF EV Functional Studies.

[1]  D. Hoja-Łukowicz,et al.  The hidden potential of glycomarkers: Glycosylation studies in the service of cancer diagnosis and treatment. , 2023, Biochimica et biophysica acta. Reviews on cancer.

[2]  M. Thaysen‐Andersen,et al.  Critical considerations in N-glycoproteomics. , 2023, Current opinion in chemical biology.

[3]  Jennifer C. Jones,et al.  A compendium of single extracellular vesicle flow cytometry , 2023, Journal of extracellular vesicles.

[4]  Nick C Fox,et al.  Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease , 2022, Nature Genetics.

[5]  Lesley Cheng,et al.  Brain Tissue-Derived Extracellular Vesicles in Alzheimer’s Disease Display Altered Key Protein Levels Including Cell Type-Specific Markers , 2022, Journal of Alzheimer's disease : JAD.

[6]  K. Datta,et al.  Comparative analysis of tangential flow filtration and ultracentrifugation, both combined with subsequent size exclusion chromatography, for the isolation of small extracellular vesicles , 2022, Journal of extracellular vesicles.

[7]  M. Marelli,et al.  Comparing digital detection platforms in high sensitivity immune‐phenotyping of extracellular vesicles , 2022, Journal of Extracellular Biology.

[8]  B. Mollenhauer,et al.  CSF-derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathology. , 2022, Brain : a journal of neurology.

[9]  B. Heijs,et al.  High-Throughput Glycomic Methods , 2022, Chemical reviews.

[10]  B. Lomonte,et al.  Characterization of Extracellular Vesicles Secreted by a Clinical Isolate of Naegleria fowleri and Identification of Immunogenic Components within Their Protein Cargo , 2022, Biology.

[11]  D. Galasko,et al.  Differential Effects of APOE Genotype on MicroRNA Cargo of Cerebrospinal Fluid Extracellular Vesicles in Females With Alzheimer’s Disease Compared to Males , 2022, Frontiers in Cell and Developmental Biology.

[12]  A. Castañeyra-Perdomo,et al.  AQP4 labels a subpopulation of white matter-dependent glial radial cells affected by pediatric hydrocephalus, and its expression increased in glial microvesicles released to the cerebrospinal fluid in obstructive hydrocephalus , 2022, Acta Neuropathologica Communications.

[13]  Mario Kurtjak,et al.  Extracellular Vesicles from Human Cerebrospinal Fluid Are Effectively Separated by Sepharose CL-6B—Comparison of Four Gravity-Flow Size Exclusion Chromatography Methods , 2022, Biomedicines.

[14]  Rebecca A. Reiman,et al.  A Novel Tissue Atlas and Online Tool for the Interrogation of Small RNA Expression in Human Tissues and Biofluids , 2022, Frontiers in Cell and Developmental Biology.

[15]  Jing Ma,et al.  Expression Profiles of Exosomal MicroRNAs Derived from Cerebrospinal Fluid in Patients with Congenital Hydrocephalus Determined by MicroRNA Sequencing , 2022, Disease markers.

[16]  J. Griffith,et al.  Imaging of surface microdomains on individual extracellular vesicles in 3‐D , 2022, Journal of extracellular vesicles.

[17]  Y. Mechref,et al.  Glycomic and Glycoproteomic Techniques in Neurodegenerative Disorders and Neurotrauma: Towards Personalized Markers , 2022, Cells.

[18]  J. Kawada,et al.  MicroRNA expression profiling of cerebrospinal fluid/serum exosomes in children with human herpesvirus 6-associated encephalitis/encephalopathy by high-throughput sequencing , 2022, Journal of NeuroVirology.

[19]  Y. Gui,et al.  Cerebrospinal Fluid Extracellular Vesicles with Distinct Properties in Autoimmune Encephalitis and Herpes Simplex Encephalitis , 2022, Molecular Neurobiology.

[20]  Helle H Damkier,et al.  A Brief Overview of the Cerebrospinal Fluid System and Its Implications for Brain and Spinal Cord Diseases , 2022, Frontiers in Human Neuroscience.

[21]  H. Struyfs,et al.  Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers. , 2022, Brain : a journal of neurology.

[22]  Yong Cheng,et al.  Metabolomic Identification of Serum Exosome-Derived Biomarkers for Bipolar Disorder , 2022, Oxidative medicine and cellular longevity.

[23]  S. Gygi,et al.  Human neural cell type‐specific extracellular vesicle proteome defines disease‐related molecules associated with activated astrocytes in Alzheimer's disease brain , 2022, Journal of extracellular vesicles.

[24]  B. Teter,et al.  Multi-Omics Analysis of Microglial Extracellular Vesicles From Human Alzheimer’s Disease Brain Tissue Reveals Disease-Associated Signatures , 2021, Frontiers in Pharmacology.

[25]  G. Church,et al.  Framework for rapid comparison of extracellular vesicle isolation methods , 2021, eLife.

[26]  Tianbai Li,et al.  Role of Glia-Derived Extracellular Vesicles in Neurodegenerative Diseases , 2021, Frontiers in Aging Neuroscience.

[27]  R. Vandenbroucke,et al.  Involvement of the Choroid Plexus in the Pathogenesis of Niemann-Pick Disease Type C , 2021, Frontiers in Cellular Neuroscience.

[28]  Matthew S. Gentry,et al.  Emerging roles of N-linked glycosylation in brain physiology and disorders , 2021, Trends in Endocrinology & Metabolism.

[29]  S. Kristensen,et al.  Characterising Alzheimer's disease through integrative NMR- and LC-MS-based metabolomics , 2021, Metabolism open.

[30]  Björn M. Burmann,et al.  Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders , 2021, Acta Neuropathologica.

[31]  B. Kuster,et al.  High sensitivity glycomics in biomedicine , 2021, Mass spectrometry reviews.

[32]  R. Carney,et al.  Surface enhanced Raman scattering of extracellular vesicles for cancer diagnostics despite isolation dependent lipoprotein contamination , 2021, Nanoscale.

[33]  R. Vandenbroucke,et al.  Importance of extracellular vesicle secretion at the blood–cerebrospinal fluid interface in the pathogenesis of Alzheimer’s disease , 2021, Acta neuropathologica communications.

[34]  R. Dale,et al.  Cerebrospinal fluid metabolomics: detection of neuroinflammation in human central nervous system disease , 2021, Clinical & translational immunology.

[35]  Jianye Xu,et al.  The dual role of glioma exosomal microRNAs: glioma eliminates tumor suppressor miR-1298-5p via exosomes to promote immunosuppressive effects of MDSCs , 2021, Cell Death & Disease.

[36]  Yanhua Qi,et al.  Exosomal miR-1246 from glioma patient body fluids drives the differentiation and activation of myeloid-derived suppressor cells. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

[37]  L. Tan,et al.  Associations of Alcohol Consumption with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study. , 2021, Journal of Alzheimer's disease : JAD.

[38]  L. Tjernberg,et al.  What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease? , 2021, Biomolecules.

[39]  Guang Yang,et al.  The anesthetic sevoflurane induces tau trafficking from neurons to microglia , 2021, Communications Biology.

[40]  C. D. Fowler,et al.  Huntington's disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization. , 2021, The Journal of clinical investigation.

[41]  G. Palmisano,et al.  Protein glycosylation in extracellular vesicles: Structural characterization and biological functions. , 2021, Molecular immunology.

[42]  M. Mattson,et al.  Neuronal and Astrocytic Extracellular Vesicle Biomarkers in Blood Reflect Brain Pathology in Mouse Models of Alzheimer’s Disease , 2021, Cells.

[43]  Jason J. Davis,et al.  Validation of α‐Synuclein in L1CAM‐Immunocaptured Exosomes as a Biomarker for the Stratification of Parkinsonian Syndromes , 2021, Movement disorders : official journal of the Movement Disorder Society.

[44]  L. Mahal,et al.  Sweet systems: technologies for glycomic analysis and their integration into systems biology , 2021, Critical reviews in biochemistry and molecular biology.

[45]  T. Montine,et al.  Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein–Containing Extracellular Vesicles , 2021, Neurology.

[46]  Yue Zhao,et al.  ABCA1-Labeled Exosomes in Serum Contain Higher MicroRNA-193b Levels in Alzheimer's Disease , 2021, BioMed research international.

[47]  Maria Teresa Dell'Anno,et al.  Proteomics Profiling of Neuron-Derived Small Extracellular Vesicles from Human Plasma: Enabling Single-Subject Analysis , 2021, International journal of molecular sciences.

[48]  A. Kaelin-Lang,et al.  Profiling Inflammatory Extracellular Vesicles in Plasma and Cerebrospinal Fluid: An Optimized Diagnostic Model for Parkinson’s Disease , 2021, Biomedicines.

[49]  L. Ramenghi,et al.  Potential biomarkers of childhood brain tumor identified by proteomics of cerebrospinal fluid from extraventricular drainage (EVD) , 2021, Scientific Reports.

[50]  B. Yoo,et al.  Molecular Signature of Extracellular Vesicular Small Non-Coding RNAs Derived from Cerebrospinal Fluid of Leptomeningeal Metastasis Patients: Functional Implication of miR-21 and Other Small RNAs in Cancer Malignancy , 2021, Cancers.

[51]  C. Reis,et al.  Glycosylation of Cancer Extracellular Vesicles: Capture Strategies, Functional Roles and Potential Clinical Applications , 2021, Cells.

[52]  Kentaro Otake,et al.  Analysis of Cerebrospinal Fluid Extracellular Vesicles by Proximity Extension Assay: A Comparative Study of Four Isolation Kits , 2020, International journal of molecular sciences.

[53]  K. Pienta,et al.  Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture medium , 2020, Journal of extracellular vesicles.

[54]  E. van der Pol,et al.  MIFlowCyt‐EV: The Next Chapter in the Reporting and Reliability of Single Extracellular Vesicle Flow Cytometry Experiments , 2020, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[55]  Quanzhong Tang,et al.  Metabolomic Identification of Exosome-Derived Biomarkers for Schizophrenia: A Large Multicenter Study. , 2020, Schizophrenia bulletin.

[56]  H. Hirano,et al.  Proteomic analysis of exosome-enriched fractions derived from cerebrospinal fluid of amyotrophic lateral sclerosis patients , 2020, Neuroscience Research.

[57]  G. Boons,et al.  Identification of Isomeric N‐Glycans by Conformer Distribution Fingerprinting using Ion Mobility Mass Spectrometry , 2020, Chemistry.

[58]  A. Janowsky,et al.  Methamphetamine use alters human plasma extracellular vesicles and their microRNA cargo: An exploratory study , 2020, Journal of extracellular vesicles.

[59]  Yang Cai,et al.  Exosomal LGALS9 in the cerebrospinal fluid of glioblastoma patients suppressed dendritic cell antigen presentation and cytotoxic T-cell immunity , 2020, Cell Death & Disease.

[60]  Jinzhong Xu,et al.  Association of Cigarette Smoking With Cerebrospinal Fluid Biomarkers of Neurodegeneration, Neuroinflammation, and Oxidation , 2020, JAMA network open.

[61]  S. Qi,et al.  A Panel of Exosome-Derived miRNAs of Cerebrospinal Fluid for the Diagnosis of Moyamoya Disease , 2020, Frontiers in Neuroscience.

[62]  Suqin Jin,et al.  Detection and significance of exosomal mRNA expression profiles in the cerebrospinal fluid of patients with meningeal carcinomatosis , 2020, Journal of Molecular Neuroscience.

[63]  Jason J. Davis,et al.  Facile Impedimetric Analysis of Neuronal Exosome Markers in Parkinson’s Disease Diagnostics , 2020, Analytical chemistry.

[64]  Nicholas M Riley,et al.  A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry-based Glycoproteomics. , 2020, Molecular & cellular proteomics : MCP.

[65]  H. Schipper,et al.  Characterization and heme oxygenase‐1 content of extracellular vesicles in human biofluids , 2020, Journal of neurochemistry.

[66]  Y. Abe,et al.  O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer , 2020, Cancers.

[67]  S. Gygi,et al.  Proteomic Profiling of Extracellular Vesicles Derived from Cerebrospinal Fluid of Alzheimer’s Disease Patients: A Pilot Study , 2020, Cells.

[68]  C. Masters,et al.  Characterization of brain‐derived extracellular vesicle lipids in Alzheimer's disease , 2020, bioRxiv.

[69]  M. Turner,et al.  CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis , 2020, Clinical Proteomics.

[70]  A. Regev,et al.  L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma , 2020, Nature Methods.

[71]  B. Yoo,et al.  Nanoparticles in 472 Human Cerebrospinal Fluid: Changes in Extracellular Vesicle Concentration and miR-21 Expression as a Biomarker for Leptomeningeal Metastasis , 2020, Cancers.

[72]  Ying Wang,et al.  Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer’s dementia , 2020, Translational Neurodegeneration.

[73]  S. Kim,et al.  Exosomal microRNA expression profiles of cerebrospinal fluid in febrile seizure patients , 2020, Seizure.

[74]  W. Buchberger,et al.  Evaluation and optimization of common lipid extraction methods in cerebrospinal fluid samples. , 2020, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[75]  S. Buch,et al.  Extracellular Vesicles in Viral Infections of the Nervous System , 2020, Viruses.

[76]  P. Lőrincz,et al.  MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemia , 2020, Journal of Translational Medicine.

[77]  A. Ivanov,et al.  Technologies and Standardization in Research on Extracellular Vesicles , 2020, Trends in Biotechnology.

[78]  I. Solomon Molecular and Histologic Diagnosis of Central Nervous System Infections. , 2020, Surgical pathology clinics.

[79]  P. Cox,et al.  An miRNA fingerprint using neural-enriched extracellular vesicles from blood plasma: towards a biomarker for amyotrophic lateral sclerosis/motor neuron disease , 2020, Open Biology.

[80]  N. Tan,et al.  Quantitative proteomic characterization of microvesicles/exosomes from the cerebrospinal fluid of patients with acute bilirubin encephalopathy , 2020, Molecular medicine reports.

[81]  Maxim N. Artyomov,et al.  Single-cell RNA-seq analysis of human CSF microglia and myeloid cells in neuroinflammation , 2020, Neurology: Neuroimmunology & Neuroinflammation.

[82]  Q. Dong,et al.  Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease. , 2020, Brain : a journal of neurology.

[83]  U. Cavallaro,et al.  Different Shades of L1CAM in the Pathophysiology of Cancer Stem Cells , 2020, Journal of clinical medicine.

[84]  Jason J. Davis,et al.  Serum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[85]  M. de Carvalho,et al.  Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases , 2020, Scientific Reports.

[86]  J. Liu,et al.  A longitudinal study on α‐synuclein in plasma neuronal exosomes as a biomarker for Parkinson’s disease development and progression , 2020, European journal of neurology.

[87]  U. Frey,et al.  Extracellular vesicles isolated from patients undergoing remote ischemic preconditioning decrease hypoxia-evoked apoptosis of cardiomyoblasts after isoflurane but not propofol exposure , 2020, PloS one.

[88]  A. Emili,et al.  Assessment of separation methods for extracellular vesicles from human and mouse brain tissues and human cerebrospinal fluids. , 2020, Methods.

[89]  X. Breakefield,et al.  Glioblastomas exploit truncated O-linked glycans for local and distant immune modulation via the macrophage galactose-type lectin , 2020, Proceedings of the National Academy of Sciences.

[90]  C. Richardson,et al.  A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum , 2020, Scientific Reports.

[91]  W. Stoorvogel,et al.  A novel three step protocol to isolate extracellular vesicles from plasma or cell culture medium with both high yield and purity , 2020, Journal of extracellular vesicles.

[92]  Ashley M. Laughney,et al.  L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer , 2020, Nature Cancer.

[93]  Lesley Cheng,et al.  Influence of species and processing parameters on recovery and content of brain tissue-derived extracellular vesicles , 2020, bioRxiv.

[94]  Romaric Lacroix,et al.  MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments , 2020, Journal of extracellular vesicles.

[95]  S. Morgello,et al.  Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment , 2019, Journal of Neuroinflammation.

[96]  D. Bennett,et al.  miR-212 and miR-132 Are Downregulated in Neurally Derived Plasma Exosomes of Alzheimer’s Patients , 2019, Front. Neurosci..

[97]  P. Williamson,et al.  Quantifications of CSF Apoptotic Bodies Do Not Provide Clinical Value in Multiple Sclerosis , 2019, Front. Neurol..

[98]  P. Shaw,et al.  Disrupted glycosylation of lipids and proteins is a cause of neurodegeneration , 2019, Brain : a journal of neurology.

[99]  Philip S. Insel,et al.  Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease , 2019, EMBO molecular medicine.

[100]  P. Siljander,et al.  Metabolomics Applied to the Study of Extracellular Vesicles , 2019, Metabolites.

[101]  Oliver C. Grant,et al.  O-glycosylation on cerebrospinal fluid and plasma Apolipoprotein E differs in the lipid binding domain. , 2019, Glycobiology.

[102]  S. Gygi,et al.  Proteomic Profiling of Extracellular Vesicles Isolated From Cerebrospinal Fluid of Former National Football League Players at Risk for Chronic Traumatic Encephalopathy , 2019, Front. Neurosci..

[103]  W. Maier,et al.  A combined miRNA–piRNA signature to detect Alzheimer’s disease , 2019, Translational Psychiatry.

[104]  Qiwei Yang,et al.  Exosomal Circular RNA as a Biomarker Platform for the Early Diagnosis of Immune-Mediated Demyelinating Disease , 2019, Front. Genet..

[105]  K. Choong,et al.  Collection and Analyses of Cerebrospinal Fluid for Pediatric Translational Research. , 2019, Pediatric neurology.

[106]  R. Petersen,et al.  Population-Based Evaluation of Lumbar Puncture Opening Pressures , 2019, Front. Neurol..

[107]  J. Falcón-Pérez,et al.  Assessing the role of surface glycans of extracellular vesicles on cellular uptake , 2019, Scientific Reports.

[108]  Zhenping Liu,et al.  Rapid and Quantitative Analysis of Exosomes by a Chemiluminescence Immunoassay Using Superparamagnetic Iron Oxide Particles. , 2019, Journal of biomedical nanotechnology.

[109]  M. Onofrj,et al.  Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis. , 2019, Journal of proteomics.

[110]  M. Kiebler,et al.  Choroid plexus‐derived miR‐204 regulates the number of quiescent neural stem cells in the adult brain , 2019, The EMBO journal.

[111]  A. Raval,et al.  Sexual dimorphism in inflammasome-containing extracellular vesicles and the regulation of innate immunity in the brain of reproductive senescent females , 2019, Neurochemistry International.

[112]  S. Tong,et al.  When Ventricular Cerebrospinal Fluid Assessment Misleads: Basal Meningitis and the Importance of Lumbar Puncture Sampling , 2019, Open forum infectious diseases.

[113]  K. Estrada,et al.  BIN1 favors the spreading of Tau via extracellular vesicles , 2019, Scientific Reports.

[114]  P. Widłak,et al.  Metabolome of Exosomes: Focus on Vesicles Released by Cancer Cells and Present in Human Body Fluids , 2019, International journal of molecular sciences.

[115]  J. Falcón-Pérez,et al.  A Comprehensive Study of Vesicular and Non-Vesicular miRNAs from a Volume of Cerebrospinal Fluid Compatible with Clinical Practice , 2019, Theranostics.

[116]  S. Vakhrushev,et al.  Different isolation approaches lead to diverse glycosylated extracellular vesicle populations , 2019, Journal of extracellular vesicles.

[117]  A. Hrishi,et al.  Cerebrospinal Fluid (CSF) Analysis and Interpretation in Neurocritical Care for Acute Neurological Conditions , 2019, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

[118]  K. Xia,et al.  Identification of a potential exosomal biomarker in spinocerebellar ataxia Type 3/Machado-Joseph disease. , 2019, Epigenomics.

[119]  P. Lewczuk,et al.  Microvesicles from cerebrospinal fluid of patients with Alzheimer’s disease display reduced concentrations of tau and APP protein , 2019, Scientific Reports.

[120]  P. Lewczuk,et al.  Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease , 2019, Alzheimer's Research & Therapy.

[121]  N. Taniguchi,et al.  N‐glycome inheritance from cells to extracellular vesicles in B16 melanomas , 2019, FEBS letters.

[122]  Dylan T Burnette,et al.  Reassessment of Exosome Composition , 2019, Cell.

[123]  E. Buzás,et al.  Systems biology approaches to investigating the roles of extracellular vesicles in human diseases , 2019, Experimental & Molecular Medicine.

[124]  D. Galasko,et al.  Validation of MicroRNA Biomarkers for Alzheimer's Disease in Human Cerebrospinal Fluid. , 2019, Journal of Alzheimer's disease : JAD.

[125]  V. Fossati,et al.  Cerebrospinal fluid biomarkers link toxic astrogliosis and microglial activation to multiple sclerosis severity. , 2019, Multiple sclerosis and related disorders.

[126]  M. de Carvalho,et al.  Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis , 2019, Molecular Neurobiology.

[127]  P. Lučin,et al.  Severe Traumatic Brain Injury Induces Early Changes in the Physical Properties and Protein Composition of Intracranial Extracellular Vesicles. , 2019, Journal of neurotrauma.

[128]  H. Kamiguchi,et al.  Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid , 2019, BMC Medical Genomics.

[129]  A. Clayton,et al.  Exosomes populate the cerebrospinal fluid of preterm infants with post-haemorrhagic hydrocephalus , 2019, International Journal of Developmental Neuroscience.

[130]  D. Yellon,et al.  Comparison of small extracellular vesicles isolated from plasma by ultracentrifugation or size-exclusion chromatography: yield, purity and functional potential , 2018, Journal of extracellular vesicles.

[131]  A. Pitkänen,et al.  Precipitation-based extracellular vesicle isolation from rat plasma co-precipitate vesicle-free microRNAs , 2018, Journal of extracellular vesicles.

[132]  S. Morgello,et al.  Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy , 2018, AIDS.

[133]  Hsu-hsin Chen,et al.  Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease , 2018, Acta Neuropathologica.

[134]  M. Smrčka,et al.  MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study , 2018, PloS one.

[135]  M. Turner,et al.  UFLC‐Derived CSF Extracellular Vesicle Origin and Proteome , 2018, Proteomics.

[136]  Jing Xu,et al.  Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.

[137]  S. Realmuto,et al.  Differences in Intercellular Communication During Clinical Relapse and Gadolinium-Enhanced MRI in Patients With Relapsing Remitting Multiple Sclerosis: A Study of the Composition of Extracellular Vesicles in Cerebrospinal Fluid , 2018, Front. Cell. Neurosci..

[138]  M. Rösslein,et al.  Characterisation of particles in solution – a perspective on light scattering and comparative technologies , 2018, Science and technology of advanced materials.

[139]  Masanori Arita,et al.  MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines1 , 2018, Journal of Lipid Research.

[140]  K. Blennow,et al.  CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease , 2018, Neurology.

[141]  Maria K. Lehtinen,et al.  The ESCRT-III Protein CHMP1A Mediates Secretion of Sonic Hedgehog on a Distinctive Subtype of Extracellular Vesicles , 2018, Cell reports.

[142]  J. Cummings The National Institute on Aging—Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials , 2018, Alzheimer's & Dementia.

[143]  Liang Li,et al.  High-Performance Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry for Exosome Metabolomics. , 2018, Analytical chemistry.

[144]  M. Glatzel,et al.  N-Glycosylation of Extracellular Vesicles from HEK-293 and Glioma Cell Lines. , 2018, Analytical chemistry.

[145]  Ana Gabriela Henriques,et al.  Exosome isolation from distinct biofluids using precipitation and column-based approaches , 2018, PloS one.

[146]  Carolyn A. Harris,et al.  Cerebrospinal fluid circulation: What do we know and how do we know it? , 2018, Brain circulation.

[147]  Christopher J. Lyon,et al.  Role of Extracellular Vesicles in Viral and Bacterial Infections: Pathogenesis, Diagnostics, and Therapeutics , 2018, Theranostics.

[148]  K. Selmaj,et al.  Multiple sclerosis: Serum-derived exosomes express myelin proteins , 2018, Multiple sclerosis.

[149]  P. Dong,et al.  Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein E , 2018, Cell Death & Disease.

[150]  H. Tateno,et al.  Glycome analysis of extracellular vesicles derived from human induced pluripotent stem cells using lectin microarray , 2018, Scientific Reports.

[151]  J. Falcón-Pérez,et al.  Glycosylation of extracellular vesicles: current knowledge, tools and clinical perspectives , 2018, Journal of extracellular vesicles.

[152]  André M. N. Silva,et al.  Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation , 2018, Nature Cell Biology.

[153]  D. Selkoe,et al.  Detection of Aggregation-Competent Tau in Neuron-Derived Extracellular Vesicles , 2018, International journal of molecular sciences.

[154]  O. Slabý,et al.  Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors , 2018, Clinical chemistry and laboratory medicine.

[155]  M. Onofrj,et al.  Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients , 2018, Scientific Reports.

[156]  Hakho Lee,et al.  New Technologies for Analysis of Extracellular Vesicles. , 2018, Chemical reviews.

[157]  Henrik Zetterberg,et al.  Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease , 2018, Neurology.

[158]  T. Patel,et al.  Large Differences in Small RNA Composition Between Human Biofluids , 2018, bioRxiv.

[159]  Kevin K. W. Wang,et al.  Protein Biomarkers and Neuroproteomics Characterization of Microvesicles/Exosomes from Human Cerebrospinal Fluid Following Traumatic Brain Injury , 2018, Molecular Neurobiology.

[160]  J. Wilkins,et al.  Application of Metabolomics in Alzheimer’s Disease , 2018, Front. Neurol..

[161]  Pieter Vermeersch,et al.  Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma , 2018, Journal of Translational Medicine.

[162]  Yanan Li,et al.  The role of exosomes derived from cerebrospinal fluid of spinal cord injury in neuron proliferation in vitro , 2018, Artificial cells, nanomedicine, and biotechnology.

[163]  D. Galasko,et al.  Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype , 2018, Autophagy.

[164]  Y. Mechref,et al.  Glycosylation Changes in Brain Cancer. , 2017, ACS chemical neuroscience.

[165]  William T. Hu,et al.  Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers , 2017, Alzheimer's Research & Therapy.

[166]  C. Bettegowda,et al.  Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients , 2017, Neuro-oncology.

[167]  Joanne L Welton,et al.  Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis , 2017, Journal of extracellular vesicles.

[168]  O. Kallioniemi,et al.  Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes , 2017, Theranostics.

[169]  K. Kultima,et al.  Increased Release of Apolipoprotein E in Extracellular Vesicles Following Amyloid-β Protofibril Exposure of Neuroglial Co-Cultures , 2017, Journal of Alzheimer's disease : JAD.

[170]  Júlia Costa Glycoconjugates from extracellular vesicles: Structures, functions and emerging potential as cancer biomarkers. , 2017, Biochimica et biophysica acta. Reviews on cancer.

[171]  J. Connor,et al.  Interleukin-13 conjugated quantum dots for identification of glioma initiating cells and their extracellular vesicles. , 2017, Acta biomaterialia.

[172]  T. Montine,et al.  Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults , 2017, Alzheimer's Research & Therapy.

[173]  D. Galasko,et al.  A cerebrospinal fluid microRNA signature as biomarker for glioblastoma , 2017, Oncotarget.

[174]  K. Messer,et al.  Analysis of extracellular RNA in cerebrospinal fluid , 2017, Journal of extracellular vesicles.

[175]  A. Hill,et al.  Methodological Guidelines to Study Extracellular Vesicles. , 2017, Circulation research.

[176]  M. Bradl,et al.  Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases , 2017, Front. Immunol..

[177]  G. Szabo,et al.  Extracellular vesicle isolation: present and future. , 2017, Annals of translational medicine.

[178]  Patrizia Agostinis,et al.  EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research , 2017, Nature Methods.

[179]  Anja Schneider,et al.  The release and trans-synaptic transmission of Tau via exosomes , 2017, Molecular Neurodegeneration.

[180]  Y. Hayashizaki,et al.  Next-generation sequencing-based small RNA profiling of cerebrospinal fluid exosomes , 2017, Neuroscience Letters.

[181]  V. Gerzanich,et al.  Cerebrospinal fluid hypersecretion in pediatric hydrocephalus. , 2016, Neurosurgical focus.

[182]  Su-Hyun Kim,et al.  Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[183]  G. Jicha,et al.  Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[184]  R. Vandenbroucke,et al.  Identification of a novel mechanism of blood–brain communication during peripheral inflammation via choroid plexus‐derived extracellular vesicles , 2016, EMBO molecular medicine.

[185]  M. Esiri,et al.  Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies , 2016, Annals of clinical and translational neurology.

[186]  M. Ståhlman,et al.  The BUME method: a new rapid and simple chloroform-free method for total lipid extraction of animal tissue , 2016, Scientific Reports.

[187]  M. Griffin,et al.  Getting to know the extracellular vesicle glycome. , 2016, Molecular bioSystems.

[188]  J. Rak,et al.  Extracellular Vesicles in Brain Tumor Progression , 2016, Cellular and Molecular Neurobiology.

[189]  S. Byers,et al.  Enabling Metabolomics Based Biomarker Discovery Studies Using Molecular Phenotyping of Exosome-Like Vesicles , 2016, PloS one.

[190]  J. Iliff,et al.  Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease. , 2016, Biochimica et biophysica acta.

[191]  R. McKay,et al.  Metabolomics and Its Application to Acute Lung Diseases , 2016, Front. Immunol..

[192]  J. Akers,et al.  Comparative Analysis of Technologies for Quantifying Extracellular Vesicles (EVs) in Clinical Cerebrospinal Fluids (CSF) , 2016, PloS one.

[193]  W. Ashley,et al.  Microparticle derived proteins as potential biomarkers for cerebral vasospasm post subarachnoid hemorrhage. A preliminary study , 2016, Clinical Neurology and Neurosurgery.

[194]  Michael Y. Wang,et al.  Exosome‐mediated inflammasome signaling after central nervous system injury , 2016, Journal of neurochemistry.

[195]  B. Mollenhauer,et al.  Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies , 2015, Brain : a journal of neurology.

[196]  M. Nair,et al.  Microglia-derived HIV Nef+ exosome impairment of the blood–brain barrier is treatable by nanomedicine-based delivery of Nef peptides , 2015, Journal of NeuroVirology.

[197]  Abeer A. Alhadi,et al.  Understanding the chemistry behind the antioxidant activities of butylated hydroxytoluene (BHT): a review. , 2015, European journal of medicinal chemistry.

[198]  Henrik Zetterberg,et al.  Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction , 2015, PloS one.

[199]  T. Jiang,et al.  Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients , 2015, Oncotarget.

[200]  Sofia B. Carvalho,et al.  Extracellular Vesicles from Ovarian Carcinoma Cells Display Specific Glycosignatures , 2015, Biomolecules.

[201]  H. Freeze,et al.  Neurological aspects of human glycosylation disorders. , 2015, Annual review of neuroscience.

[202]  R. Petersen,et al.  Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study , 2015, Alzheimer's & Dementia.

[203]  A. Fagan,et al.  Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease. , 2015, JAMA neurology.

[204]  I. Nakano,et al.  miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients , 2015, Journal of Neuro-Oncology.

[205]  A. Fagan,et al.  Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease , 2015, Alzheimer's & Dementia.

[206]  Enriqueta Casal,et al.  Considerations for Applying Metabolomics to the Analysis of Extracellular Vesicles , 2014, Front. Immunol..

[207]  David M Feliciano,et al.  Cerebrospinal Fluid Extracellular Vesicles Undergo Age Dependent Declines and Contain Known and Novel Non-coding RNAs , 2014, PloS one.

[208]  Gabriele Cruciani,et al.  LC/MS lipid profiling from human serum: a new method for global lipid extraction , 2014, Analytical and Bioanalytical Chemistry.

[209]  T. Lydic,et al.  A monophasic extraction strategy for the simultaneous lipidome analysis of polar and nonpolar retina lipids[S] , 2014, Journal of Lipid Research.

[210]  Q. Lan,et al.  Glioblastoma microvesicles promote endothelial cell proliferation through Akt/beta-catenin pathway. , 2014, International journal of clinical and experimental pathology.

[211]  T. J. Cook,et al.  Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease , 2014, Acta Neuropathologica.

[212]  I. Sargent,et al.  Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing , 2014, Journal of thrombosis and haemostasis : JTH.

[213]  C. Teunissen,et al.  Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. , 2014, Journal of proteomics.

[214]  Thomas Brinker,et al.  A new look at cerebrospinal fluid circulation , 2014, Fluids and Barriers of the CNS.

[215]  V. Kopecký,et al.  Instability of cerebrospinal fluid after delayed storage and repeated freezing: a holistic study by drop coating deposition Raman spectroscopy , 2014, Clinical chemistry and laboratory medicine.

[216]  A. C. Kroksveen,et al.  Effects of Blood Contamination and the Rostro-Caudal Gradient on the Human Cerebrospinal Fluid Proteome , 2014, PloS one.

[217]  Shiliang Zhang,et al.  Embryonic Cerebrospinal Fluid Nanovesicles Carry Evolutionarily Conserved Molecules and Promote Neural Stem Cell Amplification , 2014, PloS one.

[218]  R. Nieuwland,et al.  Co-isolation of extracellular vesicles and high-density lipoproteins using density gradient ultracentrifugation , 2014, Journal of extracellular vesicles.

[219]  R. Nieuwland,et al.  Single-step isolation of extracellular vesicles by size-exclusion chromatography , 2014, Journal of extracellular vesicles.

[220]  V. Bandaru,et al.  A Biological Perspective of CSF Lipids as Surrogate Markers for Cognitive Status in HIV , 2013, Journal of Neuroimmune Pharmacology.

[221]  Bob S. Carter,et al.  miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development , 2013, PloS one.

[222]  Oana A. Tomescu,et al.  More than cell dust: microparticles isolated from cerebrospinal fluid of brain injured patients are messengers carrying mRNAs, miRNAs, and proteins. , 2013, Journal of neurotrauma.

[223]  L. Liau,et al.  BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles , 2013, Molecular therapy. Nucleic acids.

[224]  C. Jack,et al.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.

[225]  Sébastien A. Gauthier,et al.  The Exosome Secretory Pathway Transports Amyloid Precursor Protein Carboxyl-terminal Fragments from the Cell into the Brain Extracellular Space* , 2012, The Journal of Biological Chemistry.

[226]  Taim A. Muayqil,et al.  Evidence-based guideline: Diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease , 2012, Neurology.

[227]  E. Sverdlov Amedeo Avogadro's cry: What is 1 µg of exosomes? , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.

[228]  A. Vercelli,et al.  Myeloid microvesicles are a marker and therapeutic target for neuroinflammation , 2012, Annals of neurology.

[229]  Allan R. Jones,et al.  An anatomically comprehensive atlas of the adult human brain transcriptome , 2012, Nature.

[230]  Sean P. Palecek,et al.  Human Blood-Brain Barrier Endothelial Cells Derived from Pluripotent Stem Cells , 2012, Nature Biotechnology.

[231]  S. Schwab,et al.  Increased membrane shedding – indicated by an elevation of CD133-enriched membrane particles – into the CSF in partial epilepsy , 2012, Epilepsy Research.

[232]  J Chazal,et al.  Anatomy and physiology of cerebrospinal fluid. , 2011, European annals of otorhinolaryngology, head and neck diseases.

[233]  L. Mahal,et al.  Identification of a conserved glycan signature for microvesicles. , 2011, Journal of proteome research.

[234]  Giovanni B. Frisoni,et al.  The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers , 2011, Alzheimer's & Dementia.

[235]  D. G. Clark,et al.  Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.

[236]  Sascha Keller,et al.  Interaction and uptake of exosomes by ovarian cancer cells , 2011, BMC Cancer.

[237]  Steven J Collins,et al.  Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion , 2011, Nature Medicine.

[238]  Paul C Guest,et al.  Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia. , 2010, Journal of proteome research.

[239]  J. Fleming,et al.  A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking , 2009, Neurology.

[240]  X. Dong,et al.  High concentrations of procoagulant microparticles in the cerebrospinal fluid and peripheral blood of patients with acute basal ganglia hemorrhage are associated with poor outcome. , 2009, Surgical neurology.

[241]  J. Rush,et al.  The morphology and biochemistry of nanostructures provide evidence for synthesis and signaling functions in human cerebrospinal fluid , 2009, Cerebrospinal Fluid Research.

[242]  A. Hill,et al.  Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid. , 2008, Veterinary immunology and immunopathology.

[243]  Paul E. West,et al.  A comparison of atomic force microscopy (AFM) and dynamic light scattering (DLS) methods to characterize nanoparticle size distributions , 2008 .

[244]  Thomas Brinker,et al.  Multiplicity of cerebrospinal fluid functions: New challenges in health and disease , 2008, Cerebrospinal Fluid Research.

[245]  M. Wassef,et al.  The particles of the embryonic cerebrospinal fluid: How could they influence brain development? , 2008, Brain Research Bulletin.

[246]  J. Freyssinet,et al.  Generation of procoagulant microparticles in cerebrospinal fluid and peripheral blood after traumatic brain injury. , 2008, The Journal of trauma.

[247]  W. Hacke,et al.  The Stem Cell Marker Prominin‐1/CD133 on Membrane Particles in Human Cerebrospinal Fluid Offers Novel Approaches for Studying Central Nervous System Disease , 2008, Stem cells.

[248]  Victoria Wong Medication use as a confounding factor in the use of the cerebrospinal fluid tau/beta-amyloid42 ratio. , 2007, Archives of neurology.

[249]  R. M. Adibhatla,et al.  Role of Lipids in Brain Injury and Diseases. , 2007, Future lipidology.

[250]  M. Ueno Molecular anatomy of the brain endothelial barrier: an overview of the distributional features. , 2007, Current medicinal chemistry.

[251]  P. Lewczuk,et al.  International quality control survey of neurochemical dementia diagnostics , 2006, Neuroscience Letters.

[252]  R. Al-Shahi,et al.  CSF opening pressure: Reference interval and the effect of body mass index , 2006, Neurology.

[253]  P. Solich,et al.  Advantages of ultra performance liquid chromatography over high-performance liquid chromatography: comparison of different analytical approaches during analysis of diclofenac gel. , 2006, Journal of separation science.

[254]  W. Huttner,et al.  Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells , 2005, Journal of Cell Science.

[255]  Gavin Giovannoni,et al.  Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. , 2005, Archives of neurology.

[256]  Jing Zhang,et al.  Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid , 2005, Neurobiology of Aging.

[257]  S. Davies,et al.  Molecular mechanisms of cerebrospinal fluid production , 2004, Neuroscience.

[258]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[259]  J. Ekelund,et al.  No association between micrometer-sized particles in human cerebrospinal fluid and schizophrenia , 2003, Neuroscience Letters.

[260]  Dean A Seehusen,et al.  Cerebrospinal fluid analysis. , 2003, American family physician.

[261]  A. Cruickshank,et al.  National guidelines for analysis of cerebrospinal fluid for bilirubin in suspected subarachnoid haemorrhage , 2003, Annals of clinical biochemistry.

[262]  R. Nitsch,et al.  Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42. , 2003, Archives of neurology.

[263]  Shant Kumar,et al.  CD105 is important for angiogenesis: evidence and potential applications , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[264]  T. Fladby,et al.  Micrometer-sized particles in cerebrospinal fluid (CSF) in patients with schizophrenia , 2002, Neuroscience Letters.

[265]  K. Blennow,et al.  Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. , 2001, Clinical chemistry.

[266]  B. Schlaggar,et al.  Cerebrospinal fluid protein concentration in pediatric patients: defining clinically relevant reference values. , 2000, Archives of pediatrics & adolescent medicine.

[267]  L. Hagberg,et al.  Astroglial and neuronal proteins in cerebrospinal fluid as markers of CNS involvement in Lyme neuroborreliosis , 1999, European journal of neurology.

[268]  C. Gibbs,et al.  The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. , 1996, The New England journal of medicine.

[269]  Alejandra del C. Alonso,et al.  Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules , 1996, Nature Medicine.

[270]  K. Blennow,et al.  Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? , 1995, Molecular and chemical neuropathology.

[271]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[272]  J. Whitsett,et al.  Effects of lung surfactant proteolipid SP-C on the organization of model membrane lipids: a fluorescence study. , 1992, Biochimica et biophysica acta.

[273]  D. Teplow,et al.  Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin , 1988, Nature.

[274]  D. Dickson,et al.  Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. , 1988, The American journal of pathology.

[275]  K. Felgenhauer,et al.  Development of the Blood‐CSF Barrier , 1983, Developmental medicine and child neurology.

[276]  B. Weisner,et al.  Protein fractions of lumbar, cisternal, and ventricular cerebrospinal fluid Separate areas of reference , 1978, Journal of the Neurological Sciences.

[277]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[278]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[279]  N. Hattori,et al.  α-Synuclein Seeding Assay Using RT-QuIC. , 2021, Methods in molecular biology.

[280]  Yasuhiko Kizuka,et al.  Extracellular Vesicles and Glycosylation. , 2021, Advances in experimental medicine and biology.

[281]  OUP accepted manuscript , 2021, Glycobiology.

[282]  S. Realmuto,et al.  Toxic effects on astrocytes of extracellular vesicles from CSF of multiple sclerosis patients: a pilot in vitro study. , 2020, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[283]  M. Pfaffl,et al.  Propofol and Sevoflurane Differentially Impact MicroRNAs in Circulating Extracellular Vesicles during Colorectal Cancer Resection: A Pilot Study. , 2019, Anesthesiology.

[284]  Virginia Claudio,et al.  Methods for the physical characterization and quantification of extracellular vesicles in biological samples. , 2017, Biochimica et biophysica acta. General subjects.

[285]  A. Jeromin,et al.  Biomarkers in Neurodegenerative Diseases. , 2017, Advances in neurobiology.

[286]  M. de Carvalho,et al.  Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[287]  G. Giovannoni Cerebrospinal fluid analysis. , 2014, Handbook of clinical neurology.

[288]  P. Lewczuk,et al.  Ventricular and lumbar cerebrospinal fluid concentrations of Alzheimer's disease biomarkers in patients with normal pressure hydrocephalus and posttraumatic hydrocephalus. , 2014, Journal of Alzheimer's disease : JAD.

[289]  J. Zorc,et al.  Age-specific reference values for cerebrospinal fluid protein concentration in neonates and young infants. , 2011, Journal of hospital medicine.

[290]  M. D. Del Bigio,et al.  Ependymal cells: biology and pathology , 2009, Acta Neuropathologica.

[291]  D. Wishart Applications of Metabolomics in Drug Discovery and Development , 2008, Drugs in R&D.

[292]  G. Schellenberg,et al.  Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid. , 2006, Journal of Alzheimer's disease : JAD.

[293]  Mu Wang,et al.  The impact of blood contamination on the proteome of cerebrospinal fluid , 2005, Proteomics.

[294]  G. Freeman,et al.  The B7 family revisited. , 2005, Annual review of immunology.

[295]  R. Vassar BACE1: the beta-secretase enzyme in Alzheimer's disease. , 2004, Journal of molecular neuroscience : MN.

[296]  H. Reiber Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. , 2003, Restorative neurology and neuroscience.

[297]  R. Broadwell Pathways into, through, and around the fluid-brain barriers. , 1992, NIDA research monograph.

[298]  K. Blennow,et al.  Journal of Central Nervous System Disease , 2022 .